Tibesaikosaponin V is a bioactive saponin compound primarily studied for its anti-inflammatory, immunomodulatory, and potential anticancer effects. It inhibits the production of pro-inflammatory cytokines, making it a candidate for research in autoimmune, chronic inflammatory, and oncological conditions. Additionally, it exhibits antiviral properties, particularly in early-stage viral entry inhibition for respiratory infections, and antimicrobial activity against certain pathogens. Its ability to interact with cell membrane components supports investigation into its use as an adjuvant in vaccine formulations. It may also help balance the immune system. Evaluated in in vitro and in vivo models, ongoing studies focus on its bioavailability, structural optimization, and development as a therapeutic agent. It remains in the research phase without widespread clinical application.